Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2408 to 2457 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b11. [source:swissprot;acc:q96p15]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
placental thrombin inhibitor (cytoplasmic antiproteinase) (cap) (protease inhibitor 6) (pi-6). [source:swissprot;acc:p35237]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic antiproteinase 2 (cap2) (cap-2) (protease inhibitor 8) (serpin b8). [source:swissprot;acc:p50452]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leukocyte elastase inhibitor (lei) (monocyte/neutrophil elastase inhibitor) (m/nei) (ei). [source:swissprot;acc:p30740]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynactin 4. [source:refseq;acc:nm\_032486]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4644.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4470.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03883\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic cysteine conjugate-beta lyase; glutamine-phenylpyruvate aminotransferase. [source:refseq;acc:nm\_004059]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6956.32\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7223.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03836\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanine aminotransferase 2; glutamic-pyruvate transaminase 2. [source:refseq;acc:nm\_133443]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanine aminotransferase (ec 2.6.1.2) (glutamic--pyruvic transaminase) (gpt) (glutamic--alanine transaminase). [source:swissprot;acc:p24298]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6956.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7223.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0383\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dr1-associated protein 1; negative cofactor 2 alpha; dr1-associated corepressor. [source:refseq;acc:nm\_006442]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8048.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7752.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03822\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l11, mitochondrial precursor (l11mt) (cgi-113). [source:swissprot;acc:q9y3b7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3598.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3467.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03775\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s acidic ribosomal protein p1. [source:swissprot;acc:p05386]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4857.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5039.78\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03763\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin domain-containing 2; sperm-specific thioredoxin; thioredoxin domain-containing 2 (spermatozoa). [source:refseq;acc:nm\_032243]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thioredoxin (atl-derived factor) (adf) (surface associated sulphydryl protein) (sasp). [source:swissprot;acc:p10599]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
c439a6.1 (novel protein similar to heparan sulfate (glucosamine) 3-o- sulfotransferases) (fragment). [source:sptrembl;acc:q96qi5]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7355.46\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7088.93\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0376\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl 3-o-sulfotransferase 3a1; heparin-glucosamine 3-o-sulfotransferase. [source:refseq;acc:nm\_006042]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl 3-o-sulfotransferase 3b1. [source:refseq;acc:nm\_006041]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl  3-o-sulfotransferase 2; heparin-glucosamine 3-o-sulfotransferase. [source:refseq;acc:nm\_006043]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mrna decapping enzyme; histidine triad protein member 5; heat shock-like protein 1. [source:refseq;acc:nm\_014026]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2426\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tata-binding protein-associated phosphoprotein (down-regulator of transcription 1) (dr1 protein). [source:swissprot;acc:q01658]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6123.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6351.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03729\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2427\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s2 (mrp-s2) (cgi-91). [source:swissprot;acc:q9y399]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5333.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5531.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03709\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2428\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 2. [source:swissprot;acc:p51116]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7243.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7509.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03681\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2429\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 1. [source:swissprot;acc:p51114]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2430\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin nup43 (p42). [source:swissprot;acc:q8nfh3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7243.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7509.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2431\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fragile x mental retardation 1 protein (protein fmr-1) (fmrp). [source:swissprot;acc:q06787]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7242.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7508.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03676\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2432\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gcn5-like protein 1 (rt14 protein). [source:swissprot;acc:p78537]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8154.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8453.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2433\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 60s ribosomal protein l27 (l27mt) (hspc250). [source:swissprot;acc:q9p0m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4585.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4753.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0365\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2434\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd repeat domain 26. [source:refseq;acc:nm\_025160]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6423.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6655.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03619\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
activator of camp-responsive element modulator (crem) in testis; lim protein act. [source:refseq;acc:nm\_020482]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3669.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3797.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03501\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2436\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s14 (pro2640). [source:swissprot;acc:p06366]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3708.67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3584.47\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03465\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2437\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s18 (ke-3) (ke3). [source:swissprot;acc:p25232]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna, u transporter 1; snurportin-1. [source:refseq;acc:nm\_005701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7139.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7384.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03443\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative eukaryotic translation initiation factor 1a (eif-1a) (eif- 4c). [source:swissprot;acc:o75642]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3754.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3629.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03441\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u3 snornp protein 4 homolog. [source:refseq;acc:nm\_033416]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4730.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4891.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03395\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 3 mu 2 subunit (clathrin coat assembly protein ap47 homolog 2) (clathrin coat associated protein ap47 homolog 2) (golgi adaptor ap-1 47 kda protein homolog 2) (ha1 47 kda subunit homolog 2) (clathrin assembly protein assembly protein complex 1 medium chain homolog 2) (p47b). [source:swissprot;acc:p53677]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6477.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6695.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03362\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2442\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast cancer type 1 susceptibility protein. [source:swissprot;acc:p38398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5454.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5637.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0336\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle lim-protein 2 (slim 2) (four and a half lim domains protein 3) (fhl-3). [source:swissprot;acc:q13643]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3634.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3756.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03359\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2444\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adapter-related protein complex 3 mu 1 subunit (mu-adaptin 3a) (ap-3 adapter complex mu3a subunit). [source:swissprot;acc:q9y2t2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6478.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6695.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03358\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2445\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
skeletal muscle lim-protein 3 (slim 3) (lim-domain protein dral) (four and a half lim domains protein 2) (fhl-2). [source:swissprot;acc:q14192]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3633.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3754.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03353\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2446\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 16 kda polypeptide (ec 2.7.7.6) (rpb4). [source:swissprot;acc:o15514]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4031.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4166.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0335\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l13, mitochondrial (l13mt). [source:swissprot;acc:q9byd1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3730.53\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3611.05\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03309\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2448\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s16. [source:swissprot;acc:p17008]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2449\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l13a (23 kda highly basic protein). [source:swissprot;acc:p40429]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3730.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3611.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03303\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2450\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate dehydrogenase e1 component beta subunit, mitochondrial precursor (ec 1.2.4.1) (pdhe1-b). [source:swissprot;acc:p11177]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6737.15\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6957.34\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03268\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2451\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2-oxoisovalerate dehydrogenase alpha subunit, mitochondrial precursor (ec 1.2.4.4) (branched-chain alpha-keto acid dehydrogenase e1 component alpha chain) (bckdh e1-alpha). [source:swissprot;acc:p12694]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2452\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial precursor (ec 1.3.5.1) (fp) (flavoprotein subunit of complex ii). [source:swissprot;acc:p31040]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6042.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6237.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03224\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2453\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 6. [source:swissprot;acc:q9y2v7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6931.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7152.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03197\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2454\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein prh (hematopoietically expressed homeobox) (homeobox protein hex). [source:swissprot;acc:q03014]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8751.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8480.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03196\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2455\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prip-interacting protein pipmt; prip-interacting protein with methyltransferase domain. [source:refseq;acc:nm\_024831]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5978.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6166.89\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03145\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2456\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pdz/coiled-coil domain binding partner for the rho-family gtpase tc10; fused in glioblastoma; golgi associated pdz and coiled-coil motif containing protein; cftr-associated ligand. [source:refseq;acc:nm\_020399]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2457\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
yme1-like 1 isoform 3; atp-dependent metalloprotease ftsh1 homolog. [source:refseq;acc:nm\_014263]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4998.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5155.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03144\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/